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Two groups of complement components are involved in the activation of C3. 
The first includes C2, factor B (B), C4, and C3, i.e., the structural components 
of the C3 convertases of the classical and alternative pathways. The second 
contains the regulatory proteins C4-binding protein (C4-bp), factor H (H), the 
C3b/C4b receptor (CRI or C3bR), and, probably, the decay-accelerating factor 
(DAF) and gp45-70. 
C2, C4, and factor B are encoded by a cluster of genes inside the major 
histocompatibility complex (MHC), 1 a genetic association that is consistently 
found in mammalian species (reviewed in 1 and 2). The mechanisms leading to 
that linkage and its evolutionary stability are unclear, as are its functional and 
genetic onsequences. Study of the linkage relationships ofother genes that code 
for proteins involved in the activation of C3 is, therefore, of considerable interest. 
We have recently demonstrated genetics variants of C4-bp (3), H (4), and 
C3bR (5, 6) in humans and have reported that the loci coding for C4-bp and 
C3bR are very closely linked (7). We proposed (7) the hypothesis that a cluster 
of genes encoded the regulatory complement components of the activation of 
C3. We now present evidence indicating that the locus coding for factor H in 
humans is also linked to the C4BP, C3bR cluster. In addition, we show that this 
cluster of regulatory proteins egregates independently of the C2, Bf, C4A, C4B 
gene cluster and of the human C3 locus. 
Materials and Methods 
Materials. ~-Aminocaproic a id, Nonidet P-40 (NP-40), /3-mercaptoethanol, phenyl- 
methytsulfonyl fluoride, Coomassie Brilliant Blue R, and neuraminidase type V (Clostrid- 
ium perfringens) were from Sigma Chemical Co., St. Louis, MO; EDTA from Fisher 
Scientific Co., Pittsburgh, PA; ampholine (pH 3.5-10, 4-6, and 6-8) from LKB Produk- 
ter, Bromma, Sweden; N,N'-methylenebis-acrylamide, acrylamide, N,N,N ',N '-tetra- 
methylethylenediamide, ammonium persulfate, sodium dodecyl sulfate (SDS) from Bio- 
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Rad Laboratories, Richmond, CA; ultrapure urea from Schwarz-Mann Biotech, Cam- 
bridge, MA. 
Blood Samples. 230 families were included in these studies. The familial relationships 
were corroborated in all cases by several genetic polymorphisms. Some of the families 
were made available by Dr. F. Ginsberg-Fellner, Department of Pediatrics, Mount Sinai 
School of Medicine, New York and by Dr. G. Ercilla, Departamento de Inmunologia, 
Hospital Clinico y Provincial, Barcelona, Spain. 
Blood samples were obtained by venipuncture, and lymphocytes, EDTA-plasma, and 
serum were separated by standard techniques. Red blood cells were also obtained. Tests 
were done on fresh specimens whenever possible. Otherwise, samples were frozen and 
kept either in the gas phase of liquid nitrogen (lymphocytes and erythrocytes) or at -80 °C 
(serum and plasma) until used. 
Allotyping of C4-bp and H. C4BP and FH phenotyping were performed as previously 
described (8) using EDTA-plasma or EDTA-serum. Briefly, samples were treated with 
neuraminidase, immunoprecipitated with a monospecific antibody, analyzed by isoelectric 
focusing under denaturing conditions using vertical 4.5% polyacrylamide g ls, and stained 
with Coomasie Brilliant Blue. 
AUotyping of C3bR on Erythrocytes. C3bR phenotyping was performed as previously 
described (5) using blood samples collected in standard ACD (acid-citrate-dextrose, 
formula A) anticoagulant. Briefly, erythrocytes were surface labeled with ~2~I and solubi- 
lized with 1% NP-40. Samples were then immunoprecipitated with a monoclonal ntibody 
against C3bR and analyzed by slab gel SDS-polyacrylamide gelelectrophoresis according 
to the method of Laemmli using a 5% gel and autoradiography. 
Allotyping of HLA Antigens. Typing of HLA-A, -B, and -C antigens was done by the 
standard National Institutes of Health cytotoxicity echnique modified so that the reading 
was by the contrast fluorescence t chnique developed in this laboratory (9). Typing of 
HLA-DR antigens was done by the two-color fluorescence t st described by van Rood et 
al. (10). All currently recognized HLA-A, -B, -C, and -DR antigens were identifiable with 
the sera (n = 204) in our routine battery. 
Allotyping of C3. The procedure for testing this polymorphic protein was a modification 
of a previously described test (11). 
Linkage Analysis. Segregation data for the different variants fit Mendelian expecta- 
tions. Analysis of linkage was done with the Lod score method of Morton using the 
NYLIP computer program developed in this laboratory (12). Confirmation of these 
findings was done with the newly described method of multilocus analysis of linkage (13) 
using the LINKAGE computer program (14) kindly provided by Dr. J. M. Lalouel. 
Results and Discussion 
This report demonstrates the existence in humans of a cluster of genes for 
complement proteins that constitute the regulatory counterparts of  the MHC- 
linked cluster of  C3 convertase components genes. We have previously demon- 
strated that the C4BP and C3bR loci are linked in humans (7): no recombinants 
have been encountered between C4BP and C3bR in informative heterozygotes. 
We also reported that the less common allele C4BP*2 is only found in haplotypes 
that also contain the less frequent allele C3bR*B, as shown by segregation studies 
in three pedigrees. Recently, a further individual with the genotype C3bR*B,B; 
C4BP*I,2 was identified in a Dutch family. The complete inclusion of the 
C4BP*2 allele in the C3bR *B haplotype demonstrates the presence of very strong 
linkage disequilibrium. This fact, in addition to the linkage data, indicates that 
the loci coding for C4-bp and C3bR must be closely linked. The  more recently 
found polymorphism of factor H could, therefore, be analyzed for linkage to the 
haplotypes defined by C4BP and C3bR alleles, thus increasing the number of  
informative families. 
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FmURE 1. Linkage analysis between FH locus and the C3bR, C4BP linkage group..Maximum 
likelihood estimate of recombination fraction, 0, is 0.043, with corresponding maximum Lod 
score of 3.035. 
Seven two-generation families, with a total of 39 members, each contained one 
parent who was heterozygous both at the FH locus and at the C3bR-C4BP region 
(i.e., C3bR- and/or C4BP-heterozygous). There were 23 informative meioses in 
these families with only one recombinant. The values for the Lod score (logarithm 
of odds in favor of linkage) were calculated for different values of the recombi- 
nant fraction, 0, using the NYLIP program (Fig. I). The maximum Lod score 
value was estimated to be 3.035 (i.e., the odds on linkage are 1,084:1) at a 0 
value of 0.043 (i.e., 4.3. centimorgans [cM]). The only recombinant between FH 
and the C3bR-C4BP region belongs to a large pedigree (family PED) in which 
the father is a triple heterozygote C3bR*A,B; C4BP'1,2; FH*I,2 (Fig. 2). This 
crossing-over event defines the position of the FH gene as separable from the 
other two genes in the cluster. The estimated istance (4.3 cM) is, of course, 
only approximate because of the scarcity of data. 
These results have been confirmed by muitilocus linkage analysis, developed 
by Meyers et al. (13), which also allowed us to derive information from an 
additional family with five offspring that was informative for the segregation of 
the C4BP and C3bR loci. According to this approach, likelihood ratios from 
pedigrees with a double-heterozygote parent (and hence informative for only 
one of the three possible pairs of loci) were combined with data from families 
with a triple-heterozygote parent. Maximum likelihood estimates were made for 
the recombination fractions under each of the three possible gene orders. 
(Parameters included the coefficient of coincidence c,a measure of interference 
in crossing-over; the results gave no evidence for interference, with maximum 
likelihood occurring at the boundary value, c = 1.) The most likely gene order 
was either C4BP-C3bR-FH or C3bR-C4BP-FH, with Oc4ne.cabR = 0.000 and OC4BP,FH 
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FIGURE 2. Pedigree of family PED showing C3bR, C4BP, and FH genotypes. Assigned 
haplotypes are A-l-I/B-l-1 for the mother and A-1-2/B-2-1 for the father. Note that sibling 
8 (*) represents a cross-over between C3bR, C4BP on one side and FH on the other. Phenotypes 
for C3bR, C4BP, and FH were determined as described in Materials and Methods. Parental 
phenotypes are shown at the bottom of the figure for paternal (Fa) and maternal (Mo) samples. 
= 0.044, as before, with a likelihood ratio in favor of linkage of 2.77 x 105 to 1. 
In accord with large-sample theory (15), 2 Ioge (likelihood ratio) is a ×2 variate 
with two degrees of  freedom, giving P < 10 -5 for this triple-linkage group. These 
findings, therefore, define a new linkage group in man, consisting of the regu- 
latory proteins C3bR, C4-bp, and H of  the complement system. They  also provide 
information in relation to the order ing of  the three loci. 
We have previously reported that neither C4BP (3) nor  C3bR (16) are closely 
linked to the HLA-l inked gene cluster encoding the complement components 
C2, B, C4A, and C4B. These results are now updated and summarized in Table 
I, which indicates that the C4BP, C3bR, FH gene cluster segregates independently 
of  the C2, Bf, C4A, C4B gene cluster, the TCA locus ~ and the C3 locus. 
The  three proteins studied here, C3bR, C4-bp, and H, regulate the activities 
of  the classical and/or  alternative pathway C3 convertases. They all cause decay 
acceleration of  these enzymes and serve as cofactors for factor I -mediated 
cleavage of  C4b and/or  C3b. As members  of a linkage group, they form 
2 TCA, a locus ~10 cM telomeric to HLA-A, codes for class I antigens in the surface of T 
lymphocytes and is probably homologous to the Qa locus in the mouse (17). 
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TABLE I 
Lod Score Values for Linkage Between HLA, C3, or TCA Loci and RCA * 
Loci 
Number of Nonre- Lod score at 0 = 
informa- combinant/ 
tive fami- recombi- 0.0 0.05 0.10 0.15 0.20 0.25 0.30 
lies nant* 
HLA:RCA 42 103:42 -00 -23.07 -12.74 -6.87 -3.77 -1.91 -0.90 
C3:RCA 11 23:10 -00 -5.63 -3.07 -1.79 -1.03 -0.57 -0.29 
TCA:RCA 6 14:6 -00 -3.51 -1.94 -1.13 -0.64 -0.34 -0.15 
* HLA, human leukocyte antigens; TCA, T cell A locus; RCA, regulators of complement activation; 
C3, locus encoding the third complement component. 
* Under the assumption of linkage. 
haplotypes analogous to the "complotypes" of Alper et al. (18), composed of the 
four closely linked loci for the complement proteins, C2, B, C4A, and C4B. The 
alleles of C3bR, C4BP, and FH will therefore be referred to as regulators of 
complement activation (RCA) haplotype. Both the complotype gene cluster and 
the RCA gene cluster reported here consist of functionally related proteins; the 
complotype cluster consists of elements of a C3 convertase, the RCA cluster, of 
regulatory proteins for C3 convertase. Linkage disequilibrium is present between 
several pairs of complotype alleles (18), and also between the RCA alleles C4BP*2 
and C3bR*B. Larger groups of unrelated people will need to be phenotyped to 
determine RCA haplotype frequencies and to ascertain whether there is additional 
linkage disequilibria in this group. The biological significance of this new com- 
plement gene cluster, perhaps in determining disease susceptibility, remains to 
be ascertained. In view of the proposed regulation of the trafficking of C3- and 
C4-bearing immune complexes (19) and the findings of abnormalities of these 
proteins in systemic lupus erythematosus (20-22), further understanding of the 
genetics and function of this system of linked loci should provide insights into 
the control of putative immune complex-mediated illnesses. 
It is interesting that the genes coding for most of the complement components 
are arranged in clusters and that the two other linkage groups described thus far 
for human complement components (i.e., C2-Bf-C4A-C4B and C6-C7) have been 
extremely well preserved throughout evolution (1, 2, 23-25). The RCA system 
should, therefore, also be investigated from this viewpoint. An apparently incon- 
sistent situation might exist in mice because C4BP was shown to be located within 
the H-2D-Qa interval (26, 27) while FH segregated independently of the H-2 
system (28). This would indicate that C4BP and FH are not linked in the mouse. 
However, we have recently presented ata disputing the assignment of C4BP to 
the H-2 region (29). Thus, the issue of the evolutionary conservation of this 
genetic unit remains unsettled. 
This linkage group is also of interest because two of the proteins, C4-bp and 
H, are plasma glycoproteins synthesized and secreted by hepatocytes, while the 
other, C3bR, is an integral membrane glycoprotein characteristically found on 
erythrocytes and leukocytes. The functional similarity and genetic relationship 
among these molecules may well be due to their being encoded by genes with a 
common ancestral origin (7). This hypothesis, however, implies the additional 
existence of a significant structural homology, for which there are no direct 
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supporting data. On the other hand, whether or not this cluster was formed in 
that fashion, its existence may relate to possible evolutionary consequences of
the close linkage. Close linkage, for example, may favor the evolution of the 
genetic mechanisms for the control of  the integrated expression of the genes 
within the cluster, and thereby influence the homeostatic adaptability of their 
carriers. 
Summary 
A new cluster of  complement component genes, including C4BP, C3bR, and 
FH, is described. Family segregation data indicate that FH is linked to the genes 
for C4-bp and C4bR, previously reported to be linked and to maintain linkage 
disequilibrium. This cluster is not linked to the major histocompatibility complex, 
which contains the genes for the complement components, C4, C2, and factor 
B, or to the C3 locus. These data further suggest hat the organization of  genes 
for functionally related proteins in clusters may be a rule for the complement 
system. 
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